Delivery Order SPE2DB25D3306-SPE2DB25FUCVF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $1,139.18, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement to supply vaccines supporting federal medical supply chain requirements. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $4,556.72 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of September 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made to the vendor's corporate office located in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,949.80 for Shingrix vial kits under a firm fixed-price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $15,660.99 to AmerisourceBergen Drug Corp for Shingrix vial kits. The contract is firm fixed price with no set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds the place of performance for this award at its corporate office location. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,357.35 by the Defense Logistics Agency (DLA) for Shingrix vial kits, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal contracting relationship with DLA. This award falls...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 1, 2025. This firm fixed price contract, awarded on July 31, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Shingrix vial kits valued at $10,003.60 by the Defense Logistics Agency on September 3, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and operates under a competitive, non-set-aside procurement. This award is a child contract under AmerisourceBergen's significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,417.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, with an ultimate completion date of May 28, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. SHINGRIX, a recombinant zoster vaccine, is a critical preventive health...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,993.51 for Shingrix vial kits on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, fulfilling this...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCVFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,194.24 for Shingrix vial kits, with an ultimate completion date of September 2, 2025. This is a firm fixed price delivery order issued without a set-aside designation, reflecting a competitively awarded contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering diverse pharmaceutical products including vaccines, medications, medical devices, and specialized healthcare commodities. The Shingrix delivery order represents a routine vaccine supply transaction typical of the company's operations under its broader pharmaceutical prime vendor agreement, supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/29/25 |